ClinicalTrials.gov
ClinicalTrials.gov Menu

Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00953446
Recruitment Status : Suspended
First Posted : August 6, 2009
Last Update Posted : November 19, 2010
Sponsor:
Collaborators:
Dana-Farber Cancer Institute
Amgen
Information provided by:
Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : August 2011
  Study Completion Date : No date given